⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Age Related Macular Degeneration Market to Reach $16.2 billion by 2033, Globally, by 2034 at 5% CAGR: Allied Market Research
prnewswire.com
REGN
NVS
ROG
BIIB
CHRS
SNY
APLS
BHC
IONS
Novartis to build new radioligand therapy site in Denton, Texas, delivering more next‑generation treatments to patients
globenewswire.com
NVS
Novartis to build new radioligand therapy site in Denton, Texas, delivering more next‑generation treatments to patients
globenewswire.com
NVS
Novartis AG Enterprise Technology Report 2025: Digital Transformation Strategies, Innovation Programs, Technology Initiatives, Partnerships, Investment & Acquisition, Network Map
globenewswire.com
NVS
Kenai Therapeutics Appoints Blake Arnold, CFA, as Chief Business Officer
prnewswire.com
NVS
BAX
New real‑world data reinforce earlier use of Pluvicto™ before chemotherapy in metastatic castration-resistant prostate cancer
globenewswire.com
NVS
Nikon Expands Popular Monarch and Prostaff Binocular Lines
accessnewswire.com
NVS
Ivim Health GLP-1 Weight Loss: Cost Breakdown, Clinical Data, and What They Don't Tell You (2026)
accessnewswire.com
NVS
LLY
More Than 30 Million Americans Living with Rare Diseases
prnewswire.com
AMGN
SNY
AGIO
ASND
DVA
INCY
NVS
PFE
REGN
UCB
Chemotherapy Induced Peripheral Neuropathy (CIPN) Treatment Market Report 2026-2032: Revenues to Grow by $750M at 8.64% CAGR
globenewswire.com
ABBV
AMGN
PFE
BMY
MRK
REGN
SNY
TAK
NVS
GSK
HRTX